Safavi-Hemami, H
There are no known negative interactions between the two supplements, and their mechanisms of action are complementary rather than overlapping
By inhibiting glucagon production, GLP-1 receptor agonists help maintain lower blood glucose levels, preventing unwanted spikes
Mild and temporary side effects such as redness, slight swelling and temporary fatigue may occur
Start your protocol Begin treatment in-clinic or at home (if eligible)
Catherine Abbott and Dr Melissa Pitman (Flinders University of South Australia) for their gift of recombinant human DPP-4 and advice on DPP-4, Prof Dominic Geraghty (University of Tasmania) and Dr Nick Gust (Department of Primary Industries, Parks Water and Environment) for platypus serum, Ms Carlie Sawtell for echidna Gcg PCR analysis, Dr Tasman Daish and Dr Aaron Casey for tissue collection, and the China Scholarships Council and Adelaide University for supporting Chuan He
